Our results in patient-specific iPSC-CMs indicate that such defects are a direct consequence of a NaV1.5–α1-syntrophin–Kir2.1 channelosome dysfunction produced by the disruption of the DAPC that characterizes the DMD cardiomyopathy. This evidence concerns the gene KCNJ2 and cardiomyopathy.